ChiCTR2600126786 clinical trial report covering Becotatug vedotin, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07650240 clinical trial report covering Prednisone, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07649421 clinical trial report covering Darolutamide, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07649473 clinical trial report covering Iparomlimab/Tuvonralimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07649291 clinical trial report covering Duloxetine Hydrochloride, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07650656 clinical trial report covering Indocyanine Green, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600126870 clinical trial report covering Bevacizumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07652294 clinical trial report covering SPY-003, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07654530 clinical trial report covering Ipilimumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07652658 clinical trial report covering AZD-8965, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07652879 clinical trial report covering Cyclophosphamide, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07654283 clinical trial report covering AHB-137, Phase 2, endpoints, sponsor, geography, readout timing and development white space.